Literature DB >> 30651607

New therapeutic developments for Parkinson disease.

Günther Deuschl1, Rob M A de Bie2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30651607     DOI： 10.1038/s41582-019-0133-0

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Post hoc analysis of the Exenatide-PD trial-Factors that predict response.

Authors:  Dilan Athauda; Kate Maclagan; Natalia Budnik; Luca Zampedri; Steve Hibbert; Iciar Aviles-Olmos; Kashfia Chowdhury; Simon S Skene; Patricia Limousin; Thomas Foltynie
Journal:  Eur J Neurosci       Date:  2018-10-06       Impact factor: 3.386
  1 in total
  1 in total

1.  Transcriptome and Proteome Analysis in LUHMES Cells Overexpressing Alpha-Synuclein.

Authors:  Matthias Höllerhage; Markus Stepath; Michael Kohl; Kathy Pfeiffer; Oscar Wing Ho Chua; Linghan Duan; Franziska Hopfner; Martin Eisenacher; Katrin Marcus; Günter U Höglinger
Journal:  Front Neurol       Date:  2022-04-11       Impact factor: 4.003
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.